These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8428938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
    Davidson WS, Lund-Katz S, Johnson WJ, Anantharamaiah GM, Palgunachari MN, Segrest JP, Rothblat GH, Phillips MC.
    J Biol Chem; 1994 Sep 16; 269(37):22975-82. PubMed ID: 8083197
    [Abstract] [Full Text] [Related]

  • 6. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO, Therond P, Didichenko SA, Guillas I, Chapman MJ, Wright SD, Kontush A.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep 16; 1862(9):890-900. PubMed ID: 28529180
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux.
    Gillotte KL, Davidson WS, Lund-Katz S, Rothblat GH, Phillips MC.
    J Biol Chem; 1996 Sep 27; 271(39):23792-8. PubMed ID: 8798607
    [Abstract] [Full Text] [Related]

  • 8. Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein.
    Miyazaki A, Sakai M, Suginohara Y, Hakamata H, Sakamoto Y, Morikawa W, Horiuchi S.
    J Biol Chem; 1994 Feb 18; 269(7):5264-9. PubMed ID: 8106510
    [Abstract] [Full Text] [Related]

  • 9. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
    Calabresi L, Canavesi M, Bernini F, Franceschini G.
    Biochemistry; 1999 Dec 07; 38(49):16307-14. PubMed ID: 10587455
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein A-I configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process.
    Cuellar LÁ, Prieto ED, Cabaleiro LV, Garda HA.
    Biochim Biophys Acta; 2014 Jan 07; 1841(1):180-9. PubMed ID: 24201377
    [Abstract] [Full Text] [Related]

  • 11. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
    Huang W, Matsunaga A, Li W, Han H, Hoang A, Kugi M, Koga T, Sviridov D, Fidge N, Sasaki J.
    Atherosclerosis; 2001 Nov 07; 159(1):85-91. PubMed ID: 11689210
    [Abstract] [Full Text] [Related]

  • 12. The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles.
    Nagao K, Hata M, Tanaka K, Takechi Y, Nguyen D, Dhanasekaran P, Lund-Katz S, Phillips MC, Saito H.
    Biochim Biophys Acta; 2014 Jan 07; 1841(1):80-7. PubMed ID: 24120703
    [Abstract] [Full Text] [Related]

  • 13. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
    Cho KH, Durbin DM, Jonas A.
    J Lipid Res; 2001 Mar 07; 42(3):379-89. PubMed ID: 11254750
    [Abstract] [Full Text] [Related]

  • 14. Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release.
    Hajj Hassan H, Blain S, Boucher B, Denis M, Krimbou L, Genest J.
    J Lipid Res; 2005 Jul 07; 46(7):1457-65. PubMed ID: 15654121
    [Abstract] [Full Text] [Related]

  • 15. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
    Huang W, Sasaki J, Matsunaga A, Han H, Li W, Koga T, Kugi M, Ando S, Arakawa K.
    Arterioscler Thromb Vasc Biol; 2000 Jan 07; 20(1):210-6. PubMed ID: 10634820
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.
    Brown BE, Nobecourt E, Zeng J, Jenkins AJ, Rye KA, Davies MJ.
    PLoS One; 2013 Jan 07; 8(5):e65430. PubMed ID: 23741493
    [Abstract] [Full Text] [Related]

  • 17. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
    Laccotripe M, Makrides SC, Jonas A, Zannis VI.
    J Biol Chem; 1997 Jul 11; 272(28):17511-22. PubMed ID: 9211897
    [Abstract] [Full Text] [Related]

  • 18. Characterization of human apolipoprotein A-I expressed in Escherichia coli.
    Bergeron J, Frank PG, Emmanuel F, Latta M, Zhao Y, Sparks DL, Rassart E, Denèfle P, Marcel YL.
    Biochim Biophys Acta; 1997 Jan 21; 1344(2):139-52. PubMed ID: 9030191
    [Abstract] [Full Text] [Related]

  • 19. Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.
    Daniil G, Zannis VI, Chroni A.
    PLoS One; 2013 Jan 21; 8(6):e67993. PubMed ID: 23826352
    [Abstract] [Full Text] [Related]

  • 20. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
    Panzenböck U, Kritharides L, Raftery M, Rye KA, Stocker R.
    J Biol Chem; 2000 Jun 30; 275(26):19536-44. PubMed ID: 10751387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.